ES2588778T3 - Moduladores de la interacción de astrina y raptor, y usos de los mismos en la terapia del cáncer - Google Patents

Moduladores de la interacción de astrina y raptor, y usos de los mismos en la terapia del cáncer Download PDF

Info

Publication number
ES2588778T3
ES2588778T3 ES13151022.4T ES13151022T ES2588778T3 ES 2588778 T3 ES2588778 T3 ES 2588778T3 ES 13151022 T ES13151022 T ES 13151022T ES 2588778 T3 ES2588778 T3 ES 2588778T3
Authority
ES
Spain
Prior art keywords
astrin
raptor
mtorc1
cells
mtor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13151022.4T
Other languages
English (en)
Spanish (es)
Inventor
Kathrin Thedieck
Birgit Holzwarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albert Ludwigs Universität Freiburg
Original Assignee
Albert Ludwigs Universität Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Ludwigs Universität Freiburg filed Critical Albert Ludwigs Universität Freiburg
Application granted granted Critical
Publication of ES2588778T3 publication Critical patent/ES2588778T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES13151022.4T 2013-01-11 2013-01-11 Moduladores de la interacción de astrina y raptor, y usos de los mismos en la terapia del cáncer Active ES2588778T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13151022.4A EP2755027B1 (en) 2013-01-11 2013-01-11 Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapy

Publications (1)

Publication Number Publication Date
ES2588778T3 true ES2588778T3 (es) 2016-11-04

Family

ID=47563201

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13151022.4T Active ES2588778T3 (es) 2013-01-11 2013-01-11 Moduladores de la interacción de astrina y raptor, y usos de los mismos en la terapia del cáncer

Country Status (5)

Country Link
US (1) US10041933B2 (cg-RX-API-DMAC10.html)
EP (1) EP2755027B1 (cg-RX-API-DMAC10.html)
JP (1) JP6494112B2 (cg-RX-API-DMAC10.html)
ES (1) ES2588778T3 (cg-RX-API-DMAC10.html)
WO (1) WO2014108532A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11237168B2 (en) * 2019-06-26 2022-02-01 St. Jude Children's Research Hospital Method for identifying modulators of G3BP activity
CN110476877A (zh) * 2019-08-15 2019-11-22 上海交通大学医学院附属瑞金医院 一种β细胞中特异性Raptor敲除同时GFP示踪的小鼠的制备方法
CN113125747B (zh) * 2021-03-15 2022-06-14 天津医科大学 一种isPLA-Seq的高通量检测蛋白质相互作用的方法和试剂盒及其应用

Also Published As

Publication number Publication date
US10041933B2 (en) 2018-08-07
EP2755027A1 (en) 2014-07-16
JP6494112B2 (ja) 2019-04-03
WO2014108532A1 (en) 2014-07-17
EP2755027B1 (en) 2016-06-01
HK1199930A1 (en) 2015-07-24
US20150355166A1 (en) 2015-12-10
JP2016511822A (ja) 2016-04-21

Similar Documents

Publication Publication Date Title
Kaehler et al. Ataxin-2-like is a regulator of stress granules and processing bodies
Wei et al. A new mechanism of RhoA ubiquitination and degradation: Roles of SCFFBXL19 E3 ligase and Erk2
Ikeda et al. YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases
Lafranchi et al. APC/CCdh1 controls CtIP stability during the cell cycle and in response to DNA damage
Han et al. Direct cellular delivery of human proteasomes to delay tau aggregation
Chatzifrangkeskou et al. RASSF1A is required for the maintenance of nuclear actin levels
Kit Leng Lui et al. USP26 regulates TGF‐β signaling by deubiquitinating and stabilizing SMAD7
Contrepois et al. Deacetylation of H4-K16Ac and heterochromatin assembly in senescence
US20130045214A1 (en) P53 modulator and cancer target
Mariappan et al. Inhibition of CPAP–tubulin interaction prevents proliferation of centrosome‐amplified cancer cells
David-Watine Silencing nuclear pore protein Tpr elicits a senescent-like phenotype in cancer cells
Yan et al. The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress
Eid et al. Genome-wide identification of CBX2 targets: insights in the human sex development network
Quintero et al. Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma
McMahon et al. Cavin3 released from caveolae interacts with BRCA1 to regulate the cellular stress response
Ma et al. miRNA‑34a‑5p downregulation of VEGFA in endometrial stem cells contributes to the pathogenesis of endometriosis
Duan et al. Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA-damaging chemotherapy agents and radiation
JP6494112B2 (ja) アストリンとラプターの相互作用調節因子、及びその癌治療での用途
Cai et al. The mitochondrial stress-induced protein carboxyl-terminal alanine and threonine tailing (msiCAT-tailing) promotes glioblastoma tumorigenesis by modulating mitochondrial functions
Wang et al. PAK4 promotes the cytoskeletal organization and meiotic maturation via phosphorylating DDX17 in oocyte
Shanbhag et al. An ATM-dependent transcriptional silencing program is transmitted through chromatin in cis to DNA double strand breaks
CN107405402A (zh) 筛选usp4抑制剂及用其治疗的方法
Vit et al. Cellular toxicity of iHAP1 and DT-061 does not occur through PP2A-B56 targeting
Yang et al. Long noncoding RNA ENST00000458139 promotes mitochondrial dysfunction and apoptosis of podocytes in diabetic kidney disease through binding with SNRPA1
Chen et al. Ubiquitin phosphorylation accelerates protein aggregation and promotes neurodegeneration in the aging brain